Post-COVID-19-Treatment Study

Not Applicable

Recruiting

Conditions: U09.9
Post COVID-19 condition, unspecified

Registration Number: DRKS00033476

Lead Sponsor: Johannes Gutenberg-Universität Mainz, Abteilung für Klinische Psychologie, Psychotherapie und Experimentelle Psychotherapie zusammen mit der Hochschulambulanz für Forschung und Lehre der Poliklinischen Institutsambulanz für Psychotherapie

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 54

Inclusion Criteria

Post-COVID-Syndrom / Post-Covid-19-Condition based on WHO-criteria (2021)

Exclusion Criteria

Admission to intensive care or mechanical ventilation during COVID-19, somatic contradictions against exposure therapy, acute psychotic or manic symptoms according to DSM-5, acute substance use while fulfilling criteria of a substance use disorder (middle or severe) according to DSM-5; acute severe depressive disorder according to DSM-5, acute danger for self or others; inability to participate in sessions (physical, organizational), parallel psychotherapeutic treatment or participation in another intervention study and on-going criminal proceedings

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intensity of body complaints (incl. fatigue, breathing difficulties, circulatory problems, Post-Exertion-Symptoms) with Patient Health Questionnaire - 15 (PHQ-15), Fatigue Severity Scale (FSS), Scales Breathing and Circulation of the Symptom Burden Questionnaire - Long Covid (SBQ-LC), Scale Post-Exertion Malaise of the DePaul Symptom Questionnaire-2 at T0, T1, T2, T3; Symptom-related thoughts, feelings, and behaviors (symptom burden) with Somatic Symptom Disorder B - Criteria Scale (SSD-12) at T0, T1, T2, T3; Session rating with Session Rating Scale (SRS) and Group Therapy Session Evaluation form-P/T (GTS-P/T) after each single and group session; Side effects of treatment with Inventory for the balanced assessment of Negative Effects of Psychotherapy (INEP) at T1 or T2

Secondary Outcome Measures

Name	Time	Method
Disease coping with Brief Illness Perception Questionnaire (B-IPQ) at T0, T1, T2, T3; Somatosensory Amplification with Somatosensory Amplification Scale (SSAS) at T0, T1, T2, T3; Construkts of the somatoform spectrum of the Hierarchical Taxonomy of Psychopathology (HiTOP) with short-scale for the somatoform spectrum of the HiTOP zu T0, T1, T2, T3; Treatment expectations with Credibility/Expectancy Questionnaire (CEQ) at T0; Anxiety Symptoms with Generalized Anxiety Disorder Scale-7 (GAD-7) at T0, T1, T2, T3; Depressive Symptoms with Patient Health Questionnaire-9 (PHQ-9) at T0, T1, T2, T3; Impairments of work productivity and activity with Work Productivity and Activity Impairment Questionnaire (WPAI) at T0, T1, T2, T3